Market Place
Sourcing Support
Strides Pharma gets USFDA nod to market HIV drug
04 Oct 2023 //
ECONOMIC TIMES
Hagens Berman Sobol , Hilliard Announce a Class Action Antiretroviral Drugs
28 Dec 2022 //
PR NEWSWIRE
Strides Pharma`s Generic Efavirenz Receives Approval In US
21 Jun 2021 //
FDA
Antiretroviral Therapy`s +ve Impact On Global Public Health Faces Challenges
12 Aug 2019 //
FORBES
PvPI study reveals major suspected ADRs in anti-retroviral drugs
07 Aug 2019 //
PHARMABIZ
FDA Unveils 34 New and Revised Product-Specific Draft Guidances
17 May 2019 //
RAPS
Indonesia seeks to reassure HIV patients over drug supplies
14 Jan 2019 //
REUTERS
When medicine makes you sick: How tainted drugs can elude FDA inspections
11 Jan 2019 //
USA TODAY
DOJ tells Supreme Court it has lost interest in its Gilead whistleblower case
04 Dec 2018 //
FIERCE PHARMA
Teva Pharms` Generic Efavirenz; Emtricitabine; TDF Receives Approval in US
13 Nov 2018 //
FDA
Merck`s virology business may not get that from 2 new HIV drugs
31 Aug 2018 //
BIOPHARMADIVE
US approves MSD HIV drugs Delstrigo and Pifeltro
31 Aug 2018 //
PHARMA TIMES
Is Gilead Poised for a Comeback?
07 Jul 2018 //
BIOSPACE
Cipla climbs 3% on USFDA approval to HIV drug
21 Jun 2018 //
ECONOMIC TIMES
Lupin launches generic antibiotic inhalation solution in US
13 Jun 2018 //
ECONOMIC TIMES
Gilead Lawsuits: California HIV Patients File Class Action & Injury HIV Drug
09 May 2018 //
BUSINESSWIRE
Hetero Labs III Generic Efavirenz Receives Approval In US
01 May 2018 //
FDA
Strides Shasun`s Generic Efavirenz Receives Approval In US
14 Mar 2018 //
FDA
Mylan introduces generic Sustiva tablets in Us market to treat HIV
02 Feb 2018 //
PHARMABIZ
Mylan Expands Access to HIV/AIDS Medicines with Launch of First Generic Sustiva®
01 Feb 2018 //
PR NEWSWIRE
Rising Pharmaceuticals launches generic Sustiva
04 Jan 2018 //
DRUG STORE NEWS
Aurobindo Pharma’s Generic Efavirenz Receives Approval In US
19 Dec 2017 //
FDA
Seven medicines recommended for approval, including an advanced therapy
16 Dec 2017 //
EMA
FDA Confirms Paragraph IV Patent Challenge of Sustiva (Efavirenz) Capsules
27 Sep 2017 //
FDA
Mylan Launches Three Generic Antiretrovial Medicines for HIV in Canada
15 Aug 2017 //
DDDMAG
Gilead to launch injunction against Mylan & Actavis over HIV generics in Ireland
07 Jul 2017 //
PHARMAFILE
Pharmacare’s Generic Efavirenz Receives Tentative Approval In US
19 May 2017 //
FDA
Cipla’s Generic Efavirenz Receives Approval In US
16 May 2017 //
FDA
Mylan Receives Tentative Approval for "TLE400" Under PEPFAR
20 Mar 2017 //
PR NEWSWIRE
Pfizer faces first 2017 patent loss as Pristiq generics crash the party
11 Mar 2017 //
FIERCE PHARMA
Gilead’s genvoya shows significantly higher rates of virologic suppression
15 Feb 2017 //
PHARMABIZ
FDA calls for drug firms to declare costs
18 Jan 2017 //
BANGKOK POST
More essential medicines to become cheaper with NPPA’s latest notification
11 Nov 2016 //
ECONOMIC TIMES
Strides Shasun gets US health regulator tentative nod for HIV treatment drug
27 May 2016 //
ECONOMIC TIMES
Indian Generic Manufacturer Cipla Targeting US HIV Market
31 Mar 2016 //
TWOFOUR INSIGHT
Merck’s phase 3 study of once-daily Isentress in HIV-1 adults meet endpoints
23 Feb 2016 //
PHARMABIZ
Mylan Labs Generic Efavirenz approved in US to treat HIV
17 Feb 2016 //
FDA
Strides Shasun Receives Positive WHO Inspection Report for Formulation Facility
05 Feb 2016 //
TWOFOUR INSIGHT
Bristol-Myers flips its HIV pipeline to GlaxoSmithKline`s ViiV in a $3B deal
19 Dec 2015 //
REUTERS
Cipla ready to launch low dose HIV drug `Efavirenz`
01 Dec 2015 //
ECONOMIC TIMES
ViiV Healthcare Attacking, but Gilead Prepares to Strike Back
03 Nov 2015 //
MOTLEY FOOL
HIV Treatment Market Will See Slow Growth to 2023
17 Sep 2015 //
PHARMA EXEC
Gilead`s low-dose, high-impact HIV drug heads to the FDA
09 Apr 2015 //
SAN FRANSISCO BUSINESS TIMES
Which Pharma Needs Its Cash Cow Most? It`s Not Just About Numbers
05 Mar 2015 //
FIERCE PHARMA
API Manufacturer Laurus Labs Believes in Excelling in its Chosen Segments, Not in Following Trends
23 Nov 2014 //
BUSINESS TODAY
